Sort
39,280 grants matching “leukemia”
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
$347,563Michael R Green · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · CA
Zileuton as a chemopreventive agent for chronic myeloid leukemia
$347,563Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · CA
Zileuton as a chemopreventive agent for chronic myeloid leukemia
$347,563Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · CA
Zileuton as a chemopreventive agent for chronic myeloid leukemia
$347,563Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · CA
Molecular pathogenesis of MLL-AF4 leukemias
$347,535Scott A Armstrong · Boston Children'S Hospital · R01 · FY2011 · CA
Clinical Trials with Immunotoxins
$347,508Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Single-Molecule Three-Dimensional Snapshots of Nuclear Transport
$347,500Weidong Yang · Bowling Green State University · R15 · FY2010 · GM
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivo
$347,475Boris Reizis · New York University School Of Medicine · R01 · FY2017 · AG
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivo
$347,475Boris Reizis · New York University School Of Medicine · R01 · FY2018 · AG
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivo
$347,475Boris Reizis · New York University School Of Medicine · R01 · FY2019 · AG
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivo
$347,475Boris Reizis · New York University School Of Medicine · R01 · FY2016 · AG
Development of new therapeutic approaches for endometrial cancer
$347,471Suryavathi Viswanadhapalli · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Cloning of the vic1 gene, a novel retrovirus restriction factor
$347,457Tatyana V. Golovkina · University Of Chicago · R01 · FY2012 · CA
Cloning of the vic1 gene, a novel retrovirus restriction factor
$347,457Tatyana V. Golovkina · University Of Chicago · R01 · FY2011 · CA
Olig2 Antagonists for Targeted Therapy of Pediatric Astrocytomas
$347,420Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2015 · CA
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
$347,390Jonathan D. Licht · University Of Florida · R01 · FY2017 · CA
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
$347,390Jonathan D. Licht · University Of Florida · R01 · FY2018 · CA
Targeting Cancer Stem Cells
$347,370Richard J Jones · Johns Hopkins University · P01 · FY2008 · CA
Genetic Analysis of H2B Ubiquitylation in Yeast
$347,363Mary Ann Osley · University Of New Mexico Health Scis Ctr · R01 · FY2014 · GM
Epigenetic mechanisms of Ash1L in transcriptional activation
$347,360Jin He · Michigan State University · R01 · FY2018 · GM
DISCOVERY OF FIRST-IN-CLASS NSD2 DEGRADERS FOR CANCER THERAPY
$347,332Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Antileukemic effort of NK cells in HCT for pediatric AML
$347,302Wing Leung · St. Jude Children'S Research Hospital · R01 · FY2011 · CA
Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis
$347,289Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
Role of PGE2 in CNS and peripheral autoimmune disorders
$347,274Doina Ganea · Temple Univ Of The Commonwealth · R01 · FY2008 · AI
Role of PGE2 in CNS and peripheral autoimmune disorders
$347,274Doina Ganea · Temple Univ Of The Commonwealth · R01 · FY2009 · AI